Navigation Links
Rheumatologists in the EU5 Give the Highest Satisfaction and Performance Ratings to Rituxan and Benlysta for the Treatment of Systemic Lupus Erythematosus (SLE)
Date:8/8/2013

EXTON, Pa., Aug. 8, 2013 /PRNewswire/ -- BioTrends Research Group, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that rheumatologists in the EU5 countries (France, Germany, Italy, Spain, United Kingdom) give Genentech/Biogen Idec's Rituxan and GlaxoSmithKline/Human Genome Sciences's Benlysta the highest satisfaction and overall product performance ratings. Despite their lower utilization and later use in the treatment algorithm for moderate-to-severe patients, physicians report positive impressions of the drugs. Surveyed rheumatologists also believe the products outperform other agents on their ability to put the disease into remission, maintain remission and stop organ dysfunction or failure. These attributes are rated as the most important attributes when making the prescribing decision and are partially responsible for driving physicians' high ratings of the products. Surveyed rheumatologists also perceive Rituxan and Benlysta to be well-tolerated with few serious adverse events.

The TreatmentTrends®: Systemic Lupus Erythematosus (EU) report finds that biologic agents are reserved for moderate-to-severe cases of SLE. Although Rituxan is not approved to treat SLE, it is the biologic market leader in the EU5 capturing a 61 percent biologic patient share, followed by Benlysta (26 percent) and Bristol Myers Squibb's Orencia (14 percent). 

Benlysta received approval from the European Medicines Agency in July 2011. However, according to some rheumatologists participating in the study, Benlysta does not have full market approval or was not on protocol in their respective geographic locations. This was the number one reason mentioned for not trying the product. 

"Even though rheumatologists rated Rituxan and Benlysta relatively favorably, and higher than  generic hydroxychloroquine in terms of satisfaction and overall product performance, hydroxychloroquine is still the agent used most often to treat SLE, because it is a relatively low cost product that is easy to use, with moderate efficacy and a good safety profile," said BioTrends Senior Director Greta Unger. "Despite the favorable ratings for Rituxan and Benlysta, rheumatologists are still looking for new agents for their patients with moderate-to-severe SLE, especially the more difficult-to-treat patients with organ damage, such as those with CNS and renal manifestations."

About BioTrends Research Group
BioTrends Research Group provides syndicated and custom primary market research to pharmaceutical manufacturers competing in clinically evolving, specialty pharmaceutical markets. For information on BioTrends publications and research capabilities, please visit www.bio-trends.com. BioTrends is a Decision Resources Group company.

About Decision Resources Group
Decision Resources Group is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources Group at www.DecisionResourcesGroup.com.

All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.

For more information, contact:

Decision Resources
Christopher Comfort
781-993-2597
ccomfort@dresources.com


'/>"/>
SOURCE BioTrends Research Group
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Though Over One-Third of Rheumatologists Have Prescribed Xeljanz for Their Rheumatoid Arthritis Patients, Physicians are Still Concerned With the Drugs Limited Post-Marketing Experience and Risks of Infection and Malignancy
2. U.S. and European Rheumatologists Agree That a Therapys Induction of Remission is One of the Attributes That Most Influences Their Prescribing Decisions in Rheumatoid Arthritis
3. Inaugural Harris Poll Physician Pulse(SM) Study: Viagra® and Cialis® are Highest Ranked in Trust
4. Intelsius Launches Highest Performing Products
5. Elsevier / Gold Standards Kay Morgan Awarded NCPCP Highest Honor
6. Kaiser Permanente Ranks Highest in 2012 J.D. Power and Associates Employer Satisfaction Study for Second Year in a Row
7. Maximum-Strength Formulation Offers Highest Concentration and Purity
8. Food Recalls Rise to Four a Day in Third Quarter, Reaching Highest Level of Activity in Eight Quarters, According to the ExpertRECALL Index
9. Intelsius Adds to Highest Performing Products
10. U.S. Physicians Report Diabetic Nephropathy as the Renal Condition with the Highest Unmet Need for Treatment
11. MedicalBillersandcoders.com Caters to the Highest Number of Radiologists in Ohio
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... , June 26, 2016 ... care operating models within the health care industry is ... financial efficiency , Deloitte offers a suite of ... business issues impacting efficient cost optimization: labor resource analysis, ... These services facilitate better outcomes and better economics ...
(Date:6/24/2016)... , June 24, 2016   Bay Area ... Network,s Dean Center for Tick Borne Illness ... and Rehabilitation, MIT Hacking Medicine, University of California, ... today announced the five finalists of Lyme ... disease.  More than 100 scientists, clinicians, researchers, entrepreneurs, ...
(Date:6/24/2016)... BEIJING , June 24, 2016 Dehaier ... or the "Company"), which develops, markets and sells medical ... China , signed a strategic cooperation agreement with ... as "Hongyuan Supply Chain") on June 20, 2016, to ... Under the strategic cooperation agreement, Dehaier will leverage Hongyuan ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... , ... TherapySites, the leading website and online ... Counseling Association. This new relationship allows TherapySites to continue to extend their ... benefits and promotional offers. , "TCA is extremely excited about this new partnership, ...
(Date:6/26/2016)... ... , ... On June 10-11, 2016, A Forever Recovery, a holistic treatment center ... Breakfast Table in Battle Creek, MI, where the rehabilitation facility is located. This annual ... the world’s leading providers of cereal and other breakfast foods. Its residents often refer ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the ... AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center in ... topics including advance care planning, healthcare costs and patient and family engagement. , ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar ... M.D from the David Geffen School of Medicine at UCLA. He trained in Internal ... complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic events ... turn to unhealthy avenues, such as drug or alcohol abuse, as a coping mechanism. ... tools for healthy coping following a traumatic event. , Trauma sufferers tend to feel ...
Breaking Medicine News(10 mins):